Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Immunogenicity and safety of intramuscular versus subcutaneous administration of a combined measles, mumps, rubella, and varicella vaccine to children 12 to 18 months of age.

Haas H, Richard P, Eymin C, Fiquet A, Kuter B, Soubeyrand B.

Hum Vaccin Immunother. 2019;15(4):778-785. doi: 10.1080/21645515.2018.1549452. Epub 2019 Jan 8.

2.

[From vaccine manufacturing to its availability in pharmacy].

Soubeyrand B.

Rev Mal Respir. 2018 Dec;35(10):1005-1019. doi: 10.1016/j.rmr.2018.07.003. Epub 2018 Sep 25. Review. French.

PMID:
30266457
3.

The public health value of vaccination for seniors in Europe.

Esposito S, Franco E, Gavazzi G, de Miguel AG, Hardt R, Kassianos G, Bertrand I, Levant MC, Soubeyrand B, López Trigo JA.

Vaccine. 2018 May 3;36(19):2523-2528. doi: 10.1016/j.vaccine.2018.03.053. Epub 2018 Apr 1. Review.

PMID:
29615269
4.

Estimation of the individual residual risk of cervical cancer after vaccination with the nonavalent HPV vaccine.

Petry KU, Bollaerts K, Bonanni P, Stanley M, Drury R, Joura E, Kjaer SK, Meijer CJLM, Riethmuller D, Soubeyrand B, Van Damme P, Bosch X.

Hum Vaccin Immunother. 2018 Jul 3;14(7):1800-1806. doi: 10.1080/21645515.2018.1450125. Epub 2018 May 24.

5.

Safety and immune response to a challenge dose of hepatitis B vaccine in healthy children primed 10years earlier with hexavalent vaccines in a 3, 5, 11-month schedule: An open-label, controlled, multicentre trial in Italy.

Zanetti A, Desole MG, Romanò L, d'Alessandro A, Conversano M, Ferrera G, Panico MG, Tomasi A, Zoppi G, Zuliani M, Thomas S, Soubeyrand B, Eymin C, Lockhart S.

Vaccine. 2017 Jul 13;35(32):4034-4040. doi: 10.1016/j.vaccine.2017.05.047. Epub 2017 Jun 16.

PMID:
28624307
6.

Corrigendum to "Use of the nonavalent HPV vaccine in individuals previously fully or partially vaccinated with bivalent or quadrivalent HPV vaccines" [Vaccine 34 (2016) 757-761].

Van Damme P, Bonanni P, Bosch FX, Joura E, Kjaer SK, Meijer CJLM, Petry KU, Soubeyrand B, Verstraeten T, Stanley M.

Vaccine. 2016 Sep 7;34(39):4759-4760. doi: 10.1016/j.vaccine.2016.07.035. Epub 2016 Jul 25. No abstract available.

7.

Manufacturing DTaP-based combination vaccines: industrial challenges around essential public health tools.

Vidor E, Soubeyrand B.

Expert Rev Vaccines. 2016 Dec;15(12):1575-1582. Epub 2016 Jul 6. Review.

PMID:
27345296
8.

Vaccination of adults with 23-valent pneumococcal polysaccharide vaccine induces robust antibody responses against pneumococcal serotypes associated with serious clinical outcomes.

Ciprero KL, Marchese RD, Richard P, Baudin M, Sterling TM, Manoff SB, Radley D, Stek JE, Soubeyrand B, Grabenstein JD, Samson SI, Musey LK.

Hum Vaccin Immunother. 2016 Aug 2;12(8):2135-2141. Epub 2016 Mar 22.

9.

Use of the nonavalent HPV vaccine in individuals previously fully or partially vaccinated with bivalent or quadrivalent HPV vaccines.

Van Damme P, Bonanni P, Bosch FX, Joura E, Kjaer SK, Meijer CJ, Petry KU, Soubeyrand B, Verstraeten T, Stanley M.

Vaccine. 2016 Feb 3;34(6):757-61. doi: 10.1016/j.vaccine.2015.12.063. Epub 2016 Jan 6. Erratum in: Vaccine. 2016 Sep 7;34(39):4759-4760.

10.

What are the preferences of health care professionals in Germany regarding fully liquid, ready-to-use hexavalent pediatric vaccine versus hexavalent pediatric vaccine that needs reconstitution?

Lloyd AJ, Nafees B, Ziani E, Nicolas L, Fordham BA, Soubeyrand B, Bornhöft C.

Patient Prefer Adherence. 2015 Oct 27;9:1517-24. doi: 10.2147/PPA.S87229. eCollection 2015. Review.

11.

Potential impact of the human papillomavirus vaccine on the incidence proportion of genital warts in French women (EFFICAE study): a multicentric prospective observational study.

Judlin P, Jacquard AC, Carcopino X, Aubin F, Dahlab A, Mistretta F, Not D, Boelle PY, Aynaud O, Soubeyrand B.

Sex Health. 2016 Feb;13(1):49-54. doi: 10.1071/SH14218.

PMID:
26567557
12.

Assessment of preparation time with fully-liquid versus non-fully liquid paediatric hexavalent vaccines. A time and motion study.

De Coster I, Fournie X, Faure C, Ziani E, Nicolas L, Soubeyrand B, Van Damme P.

Vaccine. 2015 Jul 31;33(32):3976-82. doi: 10.1016/j.vaccine.2015.06.030. Epub 2015 Jun 17.

13.

Vaccination: an evolutionary engine for pathogens? Conference report.

Soubeyrand B, Greenberg M, Tibayrenc M, Louis J, Dutel C, Simondon F, Saadatian-Elahi M.

Infect Genet Evol. 2014 Oct;27:137-41. doi: 10.1016/j.meegid.2014.07.007. Epub 2014 Jul 19. No abstract available.

PMID:
25050487
14.

[Update on vaccine research. Proceedings of the 15th annual conference on vaccine research organized by the National Foundation for Infectious Diseases].

Aubert M, Beytout J, Callamand P, Cheymol J, Combadière B, Dahlab A, Denis F, Dodet B, Dommergues MA, Gagneur A, Gaillat J, Gavazzi G, Gras-le-Guen C, Haas H, Hau-Rainsard I, Malvy D, de Monléon JV, Picherot G, Pinquier D, Pretet JL, Pulcini C, Rabaud C, Regnier F, Rogeaux O, Savagner C, Soubeyrand B, Valdiguié M, Weil-Olivier C; Groupe Avancées Vaccinales.

Arch Pediatr. 2013 Apr;20(4):449-58. doi: 10.1016/j.arcped.2013.01.003. Epub 2013 Feb 5. French.

PMID:
23394726
16.

Immunogenicity and safety results from a randomized multicenter trial comparing a Tdap-IPV vaccine (REPEVAX®) and a tetanus monovalent vaccine in healthy adults: new considerations for the management of patients with tetanus-prone injuries.

Laurichesse H, Zimmermann U, Galtier F, Launay O, Duval X, Richard P, Sadorge C, Soubeyrand B.

Hum Vaccin Immunother. 2012 Dec 1;8(12):1875-81. doi: 10.4161/hv.22083. Epub 2012 Oct 2.

17.

[Current events in vaccination].

Aubert M, Aumaître H, Beytout J, Bloch K, Bouhour D, Callamand P, Chave C, Cheymol J, Combadière B, Dahlab A, Denis F, De Pontual L, Dodet B, Dommergues MA, Dufour V, Gagneur A, Gaillat J, Gaudelus J, Gavazzi G, Gillet Y, Gras-le-Guen C, Haas H, Hanslik T, Hau-Rainsard I, Larnaudie S, Launay O, Lorrot M, Loulergue P, Malvy D, Marchand S, Picherot G, Pinquier D, Pulcini C, Rabaud C, Regnier F, Reinert P, Sana C, Savagner C, Soubeyrand B, Stephan JL, Strady C.

Arch Pediatr. 2011 Nov;18(11):1234-46. doi: 10.1016/j.arcped.2011.07.025. Epub 2011 Oct 20. French.

PMID:
22019286
18.

Does monastic life predispose to the risk of Saint Anthony's fire (herpes zoster)?

Gaillat J, Gajdos V, Launay O, Malvy D, Demoures B, Lewden L, Pinchinat S, Derrough T, Sana C, Caulin E, Soubeyrand B.

Clin Infect Dis. 2011 Sep;53(5):405-10. doi: 10.1093/cid/cir436.

PMID:
21844022
19.

Disease-specific adverse events following nonlive vaccines: a paradoxical placebo effect or a nocebo phenomenon?

Okaïs C, Gay C, Seon F, Buchaille L, Chary E, Soubeyrand B.

Vaccine. 2011 Aug 26;29(37):6321-6. doi: 10.1016/j.vaccine.2011.05.045. Epub 2011 May 31.

PMID:
21627976
20.

Human papillomavirus (HPV) vaccination: perception and practice among French general practitioners in the year since licensing.

Lutringer-Magnin D, Kalecinski J, Barone G, Leocmach Y, Regnier V, Jacquard AC, Soubeyrand B, Vanhems P, Chauvin F, Lasset C.

Vaccine. 2011 Jul 18;29(32):5322-8. doi: 10.1016/j.vaccine.2011.05.006. Epub 2011 May 25.

PMID:
21616114
21.

Inverse correlation between varicella severity and level of anti-Varicella Zoster Virus maternal antibodies in infants below one year of age.

Pinquier D, Lécuyer A, Levy C, Gagneur A, Pradat P, Soubeyrand B, Grimprel E; Pediatricians Working Group.

Hum Vaccin. 2011 May;7(5):534-8. Epub 2011 May 1.

PMID:
21552003
22.

Human papillomavirus genotype distribution in oropharynx and oral cavity cancer in France--The EDiTH VI study.

St Guily JL, Jacquard AC, Prétet JL, Haesebaert J, Beby-Defaux A, Clavel C, Agius G, Birembaut P, Okaïs C, Léocmach Y, Soubeyrand B, Pradat P, Riethmuller D, Mougin C, Denis F.

J Clin Virol. 2011 Jun;51(2):100-4. doi: 10.1016/j.jcv.2011.03.003. Epub 2011 May 6.

PMID:
21527208
23.

[Current events in vaccination].

Aubert M, Aumaître H, Beytout J, Bloch K, Bouhour D, Callamand P, Chave C, Cheymol J, Combadière B, Dahlab A, Denis F, De Pontual L, Dodet B, Dommergues MA, Dufour V, Gagneur A, Gaillat J, Gaudelus J, Gavazzi G, Gillet Y, Gras-le-Guen C, Haas H, Hanslik T, Hau-Rainsard I, Larnaudie S, Launay O, Lorrot M, Loulergue P, Malvy D, Marchand S, Picherot G, Pinquier D, Pulcini C, Rabaud C, Regnier F, Reinert P, Sana C, Savagner C, Soubeyrand B, Stephan JL, Strady C; Groupe Avancées Vaccinales France.

Med Mal Infect. 2011 May;41(5):278-90. doi: 10.1016/j.medmal.2011.03.001. Epub 2011 Apr 13. French.

PMID:
21489733
25.

Human papillomavirus genotype distribution in tonsil cancers.

St Guily JL, Clavel C, Okaïs C, Prétet JL, Beby-Defaux A, Agius G, Birembaut P, Jacquard AC, Léocmach Y, Soubeyrand B, Riethmuller D, Denis F, Mougin C.

Head Neck Oncol. 2011 Feb 7;3(1):6. doi: 10.1186/1758-3284-3-6.

26.

Humoral immunity of dTap-IPV vaccine (REPEVAX®) administered one month after dT-IPV vaccine (REVAXIS®) in adults with unknown vaccination history.

Larnaudie S, Guiso N, Baptiste C, Desaint C, Desforges L, Lebon P, Soubeyrand B, Launay O.

Hum Vaccin. 2010 Oct;6(10):829-34. doi: 10.4161/hv.6.10.12582. Epub 2010 Oct 1.

PMID:
20864810
27.

Human papillomavirus genotype distribution in anal cancer in France: the EDiTH V study.

Abramowitz L, Jacquard AC, Jaroud F, Haesebaert J, Siproudhis L, Pradat P, Aynaud O, Leocmach Y, Soubeyrand B, Dachez R, Riethmuller D, Mougin C, Pretet JL, Denis F.

Int J Cancer. 2011 Jul 15;129(2):433-9. doi: 10.1002/ijc.25671. Epub 2010 Nov 9.

28.

Hospitalization of newborns and young infants for chickenpox in France.

Lécuyer A, Levy C, Gaudelus J, Floret D, Soubeyrand B, Caulin E, Cohen R, Grimprel E; Pediatricians Working Group.

Eur J Pediatr. 2010 Oct;169(10):1293-7. doi: 10.1007/s00431-010-1212-9. Epub 2010 May 12.

PMID:
20461528
29.

Challenge with hepatitis B vaccine in children previously vaccinated with a hepatitis B-containing combination vaccine.

Reinert P, Cinquetti S, Soubeyrand B, Biasio LR, Meghlaoui G, Thomas S, Watson M.

Adv Ther. 2010 Jan;27(1):28-38. doi: 10.1007/s12325-010-0005-x. Epub 2010 Feb 25. Erratum in: Adv Ther. 2010 Mar;27(3):192.

PMID:
20182924
30.

[Hospitalization for varicella before 3 months of age in France].

Lécuyer A, Levy C, Gaudelus J, Soubeyrand B, Caulin E, Grimprel E; les Pédiatres de l'Observatoire National des Varicelles Hospitalisées.

Arch Pediatr. 2009 Jun;16(6):924-5. doi: 10.1016/S0929-693X(09)74205-8. French. No abstract available.

PMID:
19541223
31.

[Paediatric hospitalizations for varicella in France: 2003-2007].

Lécuyer A, Levy C, Gaudelus J, de La Rocque F, Soubeyrand B, Caulin E, Grimprel E; les Pédiatres de l'Observatoire National des Varicelles Hospitalisées.

Arch Pediatr. 2009 Jun;16(6):921-3. doi: 10.1016/S0929-693X(09)74204-6. French. No abstract available.

PMID:
19541222
32.

Prevalence of anti-varicella-zoster virus antibodies in French infants under 15 months of age.

Pinquier D, Gagneur A, Balu L, Brissaud O, Gras Le Guen C, Hau-Rainsard I, Mory O, Picherot G, De Pontual L, Stephan JL, Maple P, Breuer J, Aubert M, Caulin E, Sana C, Pradat P, Soubeyrand B, Reinert P.

Clin Vaccine Immunol. 2009 Apr;16(4):484-7. doi: 10.1128/CVI.00397-08. Epub 2009 Jan 28.

33.

Safety of Tdap-IPV given one month after Td-IPV booster in healthy young adults: a placebo-controlled trial.

Beytout J, Launay O, Guiso N, Fiquet A, Baudin M, Richard P, Baptiste C, Soubeyrand B.

Hum Vaccin. 2009 May;5(5):315-21. Epub 2009 May 1.

PMID:
19011374
34.

Kinetics of decline of maternal measles virus-neutralizing antibodies in sera of infants in France in 2006.

Gagneur A, Pinquier D, Aubert M, Balu L, Brissaud O, De Pontual L, Gras Le Guen C, Hau-Rainsard I, Mory O, Picherot G, Stephan JL, Cohen B, Caulin E, Soubeyrand B, Reinert P.

Clin Vaccine Immunol. 2008 Dec;15(12):1845-50. doi: 10.1128/CVI.00229-08. Epub 2008 Sep 24.

35.

[Distribution of neutralizing measles serum antibodies according to age in women of childbearing age in France in 2005-2006].

Gagneur A, Pinquier D, Aubert M, Soubeyrand B, Balu L, Brissaud O, Gras-Le-Guen C, Hau-Rainsard I, Mory O, Picherot G, De Pontual L, Stephan JL, Reinert P.

Arch Pediatr. 2008 Oct;15(10):1525-30. doi: 10.1016/j.arcped.2008.07.011. Epub 2008 Sep 19. French.

PMID:
18804979
36.

Human papillomavirus genotype distribution in external acuminata condylomata: a Large French National Study (EDiTH IV).

Aubin F, Prétet JL, Jacquard AC, Saunier M, Carcopino X, Jaroud F, Pradat P, Soubeyrand B, Leocmach Y, Mougin C, Riethmuller D; EDiTH Study Group.

Clin Infect Dis. 2008 Sep 1;47(5):610-5. doi: 10.1086/590560.

PMID:
18637758
37.

Pertussis surveillance in private pediatric practices, France, 2002-2006.

Guiso N, de La Rocque F, Njamkepo E, Lécuyer A, Levy C, Romain O, Thollot F, Abitbol V, Soubeyrand B, Cohen R; French Pediatrics Groups Association Clinique et Thérapeutique Infantile du Val de Marne and Association Française de Pédiatrie Ambulatoire.

Emerg Infect Dis. 2008 Jul;14(7):1159-61. doi: 10.3201/eid1407.071246. No abstract available.

38.

Human papillomavirus genotype distribution in low-grade squamous intraepithelial lesions in France and comparison with CIN2/3 and invasive cervical cancer: the EDiTH III study.

Prétet JL, Jacquard AC, Saunier M, Clavel C, Dachez R, Gondry J, Pradat P, Soubeyrand B, Leocmach Y, Mougin C, Riethmuller D; EDiTH study group.

Gynecol Oncol. 2008 Aug;110(2):179-84. doi: 10.1016/j.ygyno.2008.04.012. Epub 2008 Jun 2.

PMID:
18514800
39.

Human papillomavirus genotype distribution in high grade cervical lesions (CIN 2/3) in France: EDITH study.

Prétet JL, Jacquard AC, Carcopino X, Monnier-Benoit S, Averous G, Soubeyrand B, Leocmach Y, Mougin C, Riethmuller D; EDITH study group.

Int J Cancer. 2008 Jan 15;122(2):424-7.

40.

Human papillomavirus (HPV) genotype distribution in invasive cervical cancers in France: EDITH study.

Prétet JL, Jacquard AC, Carcopino X, Charlot JF, Bouhour D, Kantelip B, Soubeyrand B, Leocmach Y, Mougin C, Riethmuller D; EDITH study group.

Int J Cancer. 2008 Jan 15;122(2):428-32.

41.

Paediatric varicella hospitalisations in France: a nationwide survey.

Grimprel E, Levy C, de La Rocque F, Cohen R, Soubeyrand B, Caulin E, Derrough T, Lecuyer A, d'Athis P, Gaudelus J; Pediatricians Working Group.

Clin Microbiol Infect. 2007 May;13(5):546-9. Epub 2007 Mar 22.

42.

[WITHDRAWN: Vaccination against human papillomavirus: a new vaccination for the female adolescent?]

Soubeyrand B, Leparc J.

Med Mal Infect. 2005 Oct 24. [Epub ahead of print] French.

PMID:
16256285
45.

[35-year measles, mumps, rubella vaccination assessment in France].

Reinert P, Soubeyrand B, Gauchoux R.

Arch Pediatr. 2003 Nov;10(11):948-54. French.

PMID:
14613687
46.

Microbial evolution: antitoxin vaccines and pathogen virulence.

Soubeyrand B, Plotkin SA.

Nature. 2002 Jun 6;417(6889):609-10; discussion 610.

PMID:
12050654
47.

[Central nervous system demyelinating disease following hepatitis B vaccination with GenHevac B. Review of ten years of spontaneous notifications (1989-1998)].

Soubeyrand B, Boisnard F, Bruel M, Debois H, Delattre D, Gauthier A, Soum S, Thébault C.

Presse Med. 2000 Apr 15;29(14):775-80. French.

PMID:
10816715
48.

[Expansion of pneumococcal vaccination in industrialized countries: will France join the movement?].

Fedson DS, Soubeyrand B.

Presse Med. 1998 May;27 Suppl 1:50-4. French. No abstract available.

PMID:
9779043

Supplemental Content

Loading ...
Support Center